| Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA (NCT05334277) | Sun Yat-sen University | 2022-05-06 |
| Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader (NCT05294731) | BeiGene | 2022-05-06 |
| Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation (NCT05761470) | Ying Lin | 2022-05-06 |
| Dilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome (NCT05059041) | Ohio State University | 2022-05-06 |
| Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) (NCT04921930) | Institut National de la Santé Et de la Recherche Médicale, France | 2022-05-06 |
| Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study (NCT06404840) | Tianjin Medical University Cancer Institute and Hospital | 2022-05-06 |
| A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure (NCT05285813) | M.D. Anderson Cancer Center | 2022-05-06 |
| Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) (NCT05322941) | Aelis Farma | 2022-05-06 |
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo (NCT05247489) | Incyte Corporation | 2022-05-05 |
| Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia (NCT05294328) | LENZ Therapeutics, Inc | 2022-05-05 |
| Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma (NCT05349331) | Sun Yat-sen University | 2022-05-05 |
| WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (NCT04644289) | AGO Research GmbH | 2022-05-05 |
| Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy (NCT05550246) | Brigham and Women's Hospital | 2022-05-05 |
| Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC (NCT05310643) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2022-05-05 |
| Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy (NCT05180825) | University Hospital, Strasbourg, France | 2022-05-05 |
| Effect of CS1 in Subjects With Pulmonary Arterial Hypertension (NCT05224531) | Cereno Scientific AB | 2022-05-05 |
| Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors (NCT05040360) | SWOG Cancer Research Network | 2022-05-05 |
| THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines (NCT05370040) | ImmunityBio, Inc. | 2022-05-05 |
| A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer (NCT05337137) | Bristol-Myers Squibb | 2022-05-05 |
| Hidradenitis Suppurativa Phase 2b Study of Izokibep (NCT05355805) | ACELYRIN Inc. | 2022-05-05 |
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer (NCT05371197) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-05 |
| Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets (NCT05046184) | University of Texas Southwestern Medical Center | 2022-05-05 |
| Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NCT00775476) | State University of New York - Upstate Medical University | 2022-05-05 |
| Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients (NCT04976036) | Dr. Romain Lazor | 2022-05-05 |
| Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma (NCT05385926) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-05-05 |
| Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa (NCT05020730) | Phoenicis Therapeutics | 2022-05-05 |
| To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva (NCT05090891) | Incyte Corporation | 2022-05-05 |
| HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) (NCT04732416) | Hanmi Pharmaceutical Company Limited | 2022-05-05 |
| Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation (NCT05365672) | TolerogenixX GmbH | 2022-05-04 |
| Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus (NCT04908280) | University of Rochester | 2022-05-04 |
| Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (NCT05347771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-04 |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors (NCT05229497) | Akeso | 2022-05-04 |
| Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy (NCT04423913) | Centre Hospitalier Universitaire de Nīmes | 2022-05-04 |
| Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (NCT05307874) | ImCheck Therapeutics, an Ipsen company | 2022-05-04 |
| Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects (NCT05363293) | Alzamend Neuro, Inc. | 2022-05-04 |
| Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma (NCT05187884) | St Vincent's Hospital, Sydney | 2022-05-03 |
| Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer (NCT04918186) | Canadian Cancer Trials Group | 2022-05-03 |
| A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis (NCT05213624) | Boehringer Ingelheim | 2022-05-03 |
| Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer (NCT04904302) | M.D. Anderson Cancer Center | 2022-05-03 |
| PD-L1 Expression in Lung Cancer (NCT04992715) | NanoMab Technology (UK) Limited | 2022-05-03 |
| Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies (NCT05191472) | Alfred Chung, MD | 2022-05-03 |
| Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care (NCT05315999) | Gerhild Becker | 2022-05-03 |
| Zinc Intervention in Elderly for Prevention of Pneumonia (NCT05527899) | Tufts University | 2022-05-03 |
| Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery (NCT05296681) | Howard S. Hochster, MD | 2022-05-03 |
| Voxelotor for Improving Oxygen Saturation in Adults (NCT05289570) | Duke University | 2022-05-03 |
| A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 (NCT04879329) | Seagen, a wholly owned subsidiary of Pfizer | 2022-05-03 |
| Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) (NCT05441826) | Tenet Medicines | 2022-05-03 |
| ......SMARTEST Trial...... (NCT05380713) | University Health Network, Toronto | 2022-05-03 |
| Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB (NCT05063110) | Assistance Publique - Hôpitaux de Paris | 2022-05-03 |
| Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer (NCT05296746) | SOLTI Breast Cancer Research Group | 2022-05-03 |
| HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors (NCT05102214) | Shanghai Henlius Biotech | 2022-05-03 |
| A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis (NCT04680676) | Boehringer Ingelheim | 2022-05-02 |
| A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma (NCT04700176) | Hackensack Meridian Health | 2022-05-02 |
| Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab (NCT05568212) | Fondazione Ricerca Traslazionale | 2022-05-02 |
| Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors (NCT05039073) | Emory University | 2022-05-02 |
| Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma (NCT05262855) | SOFIE | 2022-05-02 |
| Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) (NCT05646303) | Clairvoyant Therapeutics | 2022-05-02 |
| DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities (NCT05378360) | Daewoong Pharmaceutical Co. LTD. | 2022-05-02 |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy (NCT05031975) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-02 |
| De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction (NCT05255302) | Intergroupe Francophone de Cancerologie Thoracique | 2022-05-02 |
| Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC (NCT05394415) | Jiangsu Cancer Institute & Hospital | 2022-05-01 |
| The Use of Chinese Herbal Medicine and Vitamin C by Hospital Care Workers in HK to Prevent COVID-19 (NCT05360004) | Hong Kong Baptist University | 2022-05-01 |
| Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19. (NCT05433298) | Paulo Brofman | 2022-05-01 |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study (NCT04677426) | University of Kansas Medical Center | 2022-05-01 |
| MAP-guided Preemptive Therapy of aGvHD (NCT05368181) | Sichuan University | 2022-05-01 |
| Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia (NCT05442931) | Minia University | 2022-05-01 |
| 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies (NCT05506566) | First Affiliated Hospital of Fujian Medical University | 2022-05-01 |
| Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL (NCT05441761) | Peking Union Medical College Hospital | 2022-05-01 |
| Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma (NCT05316467) | Xiaojun Chen | 2022-05-01 |
| Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS (NCT07206706) | Ain Shams University | 2022-05-01 |
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei (NCT03976973) | Mucpharm Pty Ltd | 2022-05-01 |
| Sertraline Effect in Uremic Pruritis (NCT05341843) | Alexandria University | 2022-05-01 |
| Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients (NCT05433532) | The First Affiliated Hospital of Soochow University | 2022-05-01 |
| Low-dose Radiotherapy in iNHL (NCT05543070) | Chinese Academy of Medical Sciences | 2022-05-01 |
| Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer (NCT04782791) | Chinese PLA General Hospital | 2022-05-01 |
| Gram Type Infection-Specific Sepsis Identification Using Machine Learning (NCT03734484) | Dascena | 2022-05-01 |
| Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment (NCT06403787) | University of Guadalajara | 2022-05-01 |
| SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors (NCT05387044) | Zhejiang Cancer Hospital | 2022-05-01 |
| Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia (NCT05362942) | Beijing 302 Hospital | 2022-05-01 |
| HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss (NCT05365464) | Wake Forest University Health Sciences | 2022-05-01 |
| Ultrasound-guided Versus Combined Ultrasound and Fluoroscopy-guided Cervical Selective Nerve Root Block for Lower Cervical Radiculopathy: Non-inferiority Randomized Controlled Study (NCT05521373) | Mansoura University | 2022-05-01 |
| Microbial Restoration in Inflammatory Bowel Diseases (NCT04970446) | St Vincent's Hospital Melbourne | 2022-05-01 |
| Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement (NCT04323566) | Uppsala University Hospital | 2022-05-01 |
| Fibrin Sealant in Eyelid Surgery (NCT05358977) | University of Calgary | 2022-05-01 |
| Pamiparib in mCRPC With HRD or BRCA1/2 Mutation (NCT05327621) | Sun Yat-sen University | 2022-05-01 |
| Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer (NCT05241028) | Hebei Medical University Fourth Hospital | 2022-05-01 |
| Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly (NCT04938323) | Harvard Medical School (HMS and HSDM) | 2022-05-01 |
| A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 (NCT05381519) | Wuhan Institute of Biological Products Co., Ltd | 2022-05-01 |
| High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases (NCT05379803) | Hunan Province Tumor Hospital | 2022-05-01 |
| A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor (NCT05298683) | Hellenic Society of Hematology | 2022-05-01 |
| To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer (NCT05335460) | Fujian Cancer Hospital | 2022-05-01 |
| Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients. (NCT05340725) | Assiut University | 2022-05-01 |
| Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate (NCT05096169) | Weill Medical College of Cornell University | 2022-05-01 |
| Ketamine to Treat Patients With Post-comatose Disorders of Consciousness (NCT05343507) | University of Liege | 2022-05-01 |
| Omalizumab Before Onset of Exacerbations (NCT05332067) | Children's National Research Institute | 2022-05-01 |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis (NCT05240300) | BiomX, Inc. | 2022-05-01 |
| Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran) (NCT05349929) | Qazvin University Of Medical Sciences | 2022-05-01 |
| Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine (NCT05315362) | Leiden University Medical Center | 2022-05-01 |
| A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (NCT05365724) | China National Biotec Group Company Limited | 2022-05-01 |
| Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support (NCT06154044) | University Medical Centre Ljubljana | 2022-05-01 |